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Is membranoproliferative glomerulonephritis (MPGN) really decreas-
ing? A multicentric study of 1548 patients with primary GN. R.
Confalonieri, M. Baroni, B. Pagliari, M. L. Lavagni, M. T. Porn, G.
Banfi, E. Imbasciati, G. Colasanti, and G. Barbiano di Belgiojoso.
Renal Units, Ospedale Maggiore Policlinico, Niguarda-Ca 'Granda
and S. Carlo Borromeo, Milan, Italy. Some authors reported that the
incidence of MPGN within primary GN showed a reduction in the last
decade. To confirm such observation and to characterize the variations
of MPGN incidence with time, 1548 renal biopsy specimens from
patients with primary GN from January 1972 to December 1983 have
been reviewed. The series was obtained combining the experience of
three nephrological units in the same city. The study included patients
with focal glomerulosclerosis (FGS 286 patients), membranous ON
(MGN 315 patients), diffuse proliferative GN (AGN 185 patients),
diffuse crescentic GN (CGN 101 patients), IgA nephritis (IgAGN 457
patients), and MPGN (204 patients). Most patients had been diagnosed
by means of both light microscopy and immunofluorescence. To reach
a confirmed histological diagnosis and a homogeneous morphological
evaluation, biopsy specimens prior to 1972 were excluded, as well as
patients with minimal changes, advanced sclerosing GN, and unclass-
able forms. GN secondary to systemic disease have been excluded as
well. Statistical analysis has been performed by the X2 method. A
progressive decrease of number of MPGN was observed, despite the
increased total number of biopsy specimens. For simpler statistical
examination, comparison was made between three periods of 4 years
each. The incidence of MPGN was significantly lower for each of the
three periods if compared with the preceding one (P < 0.01 for period
1 vs. 2 and P < 0.001 for 2 vs. 3). The percent of MPGN was 21%, 14%,
and 6% for the three periods, respectively. Only FGS had a significant
increase for the third period if compared with the second one. No
significant difference between the three periods has been observed
regarding sex, age, nephrotic syndrome, or hypocomplementemia at
observation. The number of type 2 MPGN for each period showed no
change, thus having an increased incidence (6%, 10%, and 18%,
respectively). No modification within the total number of biopsy
specimens was found. The observation agrees with another study
performed in the Paris, France, area. The nature of the modified
incidence is obscure. Exogenous or environmental factors influencing
large population areas such as a possible decrease of etiologic agents
can be postulated.
Macrophage Fe-receptor function in idiopathic glomerulonephritis. D.
Roccatello, R. Coppo, G. Martina, C. Rollino, B. Basolo, F. Quarello,
G. Picciotto, P. G. De Filippi, D. Cordonnier, and G. Piccoli. Chair of
Medical Nephrology of University of Turin, Nephrology and Dialysis
Units and Nuclear Medicine Department, S. Giovanni Hospital, Turin,
Italy, and Centre Hospitalier Universitaire, Grenoble, France. Experi-
mental models suggest that the mononuclear phagocyte system (MPS)
plays a key role in nephropathies having an immune pathogenesis.
Methods for studying MPS immune function in vivo have only recently
been developed and data in idiopathic glomerulonephritis (GN) are
scanty. We examined 48 patients: 17 membranous GN (MGN), 8
membranoproliferative GN (MPGN), 7 focal glomeruloscierosis (FGS),
and 16 primary IgA nephropathy (IgA-N). No patient was under
treatment with steroids or immunosuppressive drugs. MPS Fe-receptor
function was detected as described by Frank by measuring the half-life
(t 1/2) of autologous lgG-sensitized red blood cells (RBC) labelled with
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51Cr (normal values: 31 6.37 mm). A MPS dysfunction was found in
62.5% of the patients with nephrotic range proteinuria and/or severe
microhematuria, but in only one out of 16 patients with minimal or
absent urinary abnormalities (proteinuria <0.7 g/day, hematuria <5
RBC/high power microscopic field). Meant 1/2 values were significantly
higher than the 95th percentile of those in 14 normal subjects with
MPGN (44.1 14 mm, P < 0.05) and IgA-N (55.7 41.6 mm, P <
0.025). A significant correlation was found, in MPGN, between t 1/2 and
proteinuria levels (r = 0.7, P < 0.05). In MGN t 1/2 values (47.2 34
mm) were not different from those of normal controls. However, a
delayed immune clearance was observed in 7 of 17 patients. Only one
out of seven FGS patients had an impaired MPS function. In IgA-N a
good correlation (P < 0.05) was found between levels of IgA containing
immune complexes (as detected by a conglutinin solid phase test) and
those oft 1/2. Conversely, no correlation was observed between values
oft 1/2 and levels of IgG immune complexes (Clq solid phase test) in
any patient group. Our results suggest that an impairment of Fe-
receptor MPS function is a frequent feature in patients with idiopathic
GN and urinary findings of active disease. The mechanism responsible
is uncertain. However, a MPS dysfunction might favor the persistence
of immunologically active substances in the bloodstream and possibly
their deposition in the kidney.
The detection of monocytes in essential cryoglobulinemia-associated
glomerulonephritis (GN): histochemical analysis in 29 patients. F. Fer-
rario, A. Castiglione, G. Colasanti, G. Barbiano di Belgioioso, C.
Bruntati, S. Nova, and G. D'Amico. Divisions of Nephrology, San
Carlo and Ca' Granda Hospital, Milan, Italy. The participation of
monocytes in the immunopathogenesis of experimental GN seems well
established. More recently, the presence of intraglomerular monocytes
has also been reported in human GN, especially in cases associated
with essential cryoglobulinemia (EC). To evaluate the presence and the
possible role of these cells, we examined cryostatic sections of renal
biopsy specimens from 29 patients with EC-associated GN, by means of
nonspecific esterase (NSE) reaction for monocytes. The number of
NSE-positive cells per glomerulus has been evaluated in all patients,
obtaining a mean index of intraglomerular monocytes (M/G) for each
biopsy. The mean value of M/G in this disease was particularly high
(30.6 22.4), and it was significantly different according to histological
subgroups: (1) diffuse proliferative GN with "thrombi" = 9 patients,
M/G 54.2 12.5; (2) diffuse proliferative GN without "thrombi" = 10
patients, M/G 32.1 14.2; (3) lobular ON = 4 patients, M/G 8.4 5.8;(4) focal proliferative GN 6 patients, M/G 6.6 6.5 (ito 2, 2 to 3, 2
to 4 = P < 0.01; 1 to 3, Ito 4 = P < 0.001). In diffuse GN with
"thrombi" interposition of monocytic cytoplasm within glomerular
basement membranes as well as a close relationship between
monocytes and "thrombi" were frequently observed. Moreover, serial
biopsy specimens in two such patients showed a disappearance of both
monocytes and endoluminal 'thrombi ." The amount of proteinuria was
the only clinical parameter correlated (although not to a significant
level) with the degree of monocyte infiltration. In the 12 patients with
M/G > 40, mean proteinuria was 4.9 5.0 g/24 hr; in the 9 patients with
M/G between 10 and 40, mean proteinuria was 3.4 2.3 g124 hr; in the
8 patients with M/G < 10, mean proteinuria was 1.2 1.5 g/24 hr. Our
results confirm a high degree of monocyte infiltration in EC-associated
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UN. In particular the strict relationship between monocytes and
cryoprecipitates ("thrombi") suggests immune adherence mechanisms
as a modality of intraglomerular recruitment of these cells and their
possible phagocytic capacity on deposited immune-complexes. Finally,
the correlation between MIU and proteinuria confirms experimental
data on the active role of monocyte/macrophage cells in inducing a
glomerular damage and determining permeability alterations of the
glomerular basement membrane.
The correlation between proteinuria and intraglomerular monocytes in
proliferative glomerulonephritis (GN). F. Ferrorio, A. Castiglione, G.
Colasanti, M. G. Lavagni, S. Bertoli, S. Nova, and G. D'Amico.
Divisions of Nephrology, San Carlo and Ca' Granda Hospitals, Milan,
Italy. Recent studies in experimental UN showed a close relationship
between intraglomerular monocyte infiltration and proteinuria: the role
of these cells in the pathogenesis of tissue damage is actually under
active investigation. To establish a possible correlation between pro-
teinuria and degree of monocyte infiltration also in human UN, we
analyzed 124 cases of biopsy-proven proliferative UN, classified as
follows: 61 systemic lupus-associated UN, 27 acute post-infectious UN,
19 crescentic UN (>80% of glomeruli with circumferential crescents),
17 membranoproliferative UN. To identify monocytes, a histochemical
method of esterase was used on cryostatic sections; the number of
esterase-positive cells per glomerulus has been evaluated in all cases,
obtaining a mean index of intraglomerular monocytes (MIU) for each
biopsy. The patients have been further divided according to the
presence of severe (MIU > 5) or moderate (MIU < 5) monocyte
infiltration and a highly significant correlation between the number of
esterase positive cells and the amount of proteinuria has been found in
each group of UN.
MIU>5 MIU<5
Protein- Protein-
No. of uria No. of uria Student's
cases g124 hr cases gI24 hr t test
Lupus UN 27 2.9 2.5 34 1.4 1.3 P < 0.01
Acute post-
infectious UN 18 2.4 2.0 9 0.8 0.5 P C 0.05
Crescentic UN 11 5.7 2.0 8 2.1 1.3 P C 0.01
Membrano-
proliferative UN 5 7.3 5.9 12 3.1 1.8 P C 0.02
Our results suggest that among multiple mechanisms leading to protein-
uria, monocyte may play a direct role in inducing glomerular damage,
possibly through the release of lytic enzymes to glomerular basement
membrane.
The action of thyroid hormones on sodium proximal tubule transport.
Effect on Na-K-ATPase activity in isolated single nephrons. G. Caposso,
R. Kinne, N. G. Dc Santo, and C. Giordano. Albert Einstein College of
Medicine, New York, New York, USA, and P Faculty of Medicine,
Naples, Itoly. Our previous studies demonstrated that fluid reabsorp-
tion (iv) by the late proximal convoluted tubule of chronically
thyroidectomized rats (TX) is reduced compared to control and is
doubled by the administration of low doses (10 LgIkgIbw) of tn-
iodothyronine (T3) for 3 days (TX + T3). To determine if the latter was
due to an increased Na-K-ATPase activity, enzyme activities were
measured in single tubule segments using a kinetic micro assay. Early
(S1) and late (S2) proximal tubule segments were isolated from the
cortex of collagenase-perfused kidneys of control, TX and TX + T3
rats. The results are summarized in the table and expressed as
picomoles of ADP generated per minute per millimeter of tubule length
(mean SEM, N number of rats, C 0.005 vs. TX).
Control TX TX + T5
S 156.1 16.8* 68.4 8.9 55.6 6.9
N (7) (6) (5)
52 50.3 4.8* 16.6 4.1 17.0 3.7
N (9) (8) (5)
The data show that Na-K-ATPase decreases following chronic
thyroidectomy, but that administration of low doses of T3 increases i.
without a change in Na-K-ATPase activity. This discrepancy between
Na-K-ATPase activity measure in vitro and i. determined in vivo might
indicate that low doses of T3 do not affect Na-K-ATPase activity
directly, but stimulate tubular transport by a different mechanism.
Diurnal variation of urinary total protein (P) and albumin (A) excre-
tion. L. Ansi, F. Capani, R. Boroni, A. La Russa, S. Alfieri, and C.
Buzio. Clinico Medico e Nefrologia, Universitd di Parmo, Pormo,
Clinico Medico Generole, Universitd di Chieti, Chieti, Itoly. Day-time
orthostatic P and A excretion is known to exceed night-time clinostatic
excretion. The changes of posture and activity are generally agreed to
be causative. But when recumbency is maintained over 24 hr, the
day-night differences persist, suggesting that other mechanisms play a
role. To improve our knowledge of the behavior of P and A excretion,
we measured it, together with that of creatinine, in eight consecutive
urine specimens carefully collected for 3-hr periods from normal
subjects (group 1; N = 16) and nephropathic patients (group 2; N = 12)
maintained at bedrest for 24 hr. P was measured by the amido-black
method according to Fleremans, A by electroimmunodiffusion method
according to Laurell, urine creatinine (Cr) by standard autoanalyzer. In
all subjects, the values of P, A, and Cr obtained in each single 3-hr
period were expressed as percents of their mean values of the eight
periods. The time relation to the average relative changes of P (—) A (--)
Cr (...) is shown in Figures 1 (left, group I) and 2 (right, group 2).
Furthermore, statistical analysis by means of the paired t test was
performed comparing the mean value for each 3-hr period with the
corresponding preceding value. Both groups show identical timing in P,
A, and Cr maximal excretion rates, but only group I shows significant
variations of P and A before and after the sole significant variation of
Cr. The last one was the only significant finding recorded in group 2. In
conclusion, in normal subjects, non-syncronous circadian rhythms
regulate urinary excretion of F, A, and Cr, independently of posture
changes. In nephropathic patients Cr rhythm is maintained while the P
and A ones are lost.
The dopaminergic response of patients with liver cirrhosis. A.
Morganti, G. Grozioni, F. Solerno, P. L. Incerti, G. Bolla, F.
Lorenzano, S. Casati, and P. Ghirordi. Institutes of Clinico Medico Ill
and IV, University of Milan, Department of Nephrology, Ospedole
Moggiore and Medical Research Unit, SIMES, Milan, Italy. The
hyponatriuria that is commonly found in patients with advanced liver
cirrhosis (ALC) is reversible on long-term infusion of dopamine. To
investigate the response of vascular and tubular dopamine receptors to
lbopamine (I), an orally active dopamine derivative, we measured
urinary flow (U mllmin), glomerular filtration rate (UFR mi/mm),
fractional excretion of sodium and potassium (FeNa% and FEK%),
plasma renin activity (PEA ng/ml/hr), and urinary aldosterone excretion
(UA ng/min) before and after the administration of 50mg 1 in II patients
with ALC. Blood and urine samples were collected prior to (time 0) and
80, 160 and 240 mm after I. The results are reported in the table (one
asterisk indicates P C 0.05).
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Time V GFR FeNa
0
80'
160'
240'
0.7 0.1
2.1 0.4*
1.1 0.2
1.2 0.3
120 10
261 31*
136 17
128 26
0.09 0.03
0.15 0.04
0.35 0.08*
0.37 0.11*
Time FeK PRA UA
0
80'
160'
240'
5.9 0.6
9.1 1.3*
11 1.7*
8.8 1.5*
1.7 0.6
0.9 0.2*
0.9 0.3*
0.9 0.3*
24 7.0
47 10*
23 8.0
25 7.0
These data indicate that the acute stimulation of the renal dopaminergic
receptors by I results in a significant natriuretic effect. This may be due
to independent vascular and tubular mechanisms since the changes in
GFR tend to disappear when those in FeNa become more evident.
Endogenous opioids and baroreflex control of heart rate in chronic
uremic patients. C. Zoccali, F. Mallamaci, M. Ciccarelli, and Q.
Maggiore. Centro Fisiologia Clinica CNR, Reggio Calabrie, Italy.
Baroreflex control of heart rate is abnormal in patients with chronic
renal failure, but the cause of this dysfunction is unknown. The
endogenous opioid Metenkephalin, which has a depressant action on
barorefiex sensitivity and is markedly elevated in plasma of chronic
uremics, could be responsible for the barorefiex dysfunction. To
evaluate this hypothesis, we tested the effect of the opiate antagonist
Nalaoxone (0.07 mg kg-1) on the response to Valsalva maneuver in
nine uremic patients (UP) on chronic dialysis and in seven healthy
subjects (HS) matched for age and sex. The experimental design was
single-blind, placebo-controlled, randomized, crossover, and balanced.
In UP Naloxone caused a progressive increase in Valsalva maneuver
ratio from a subnormal control value of 1.46 0.09 (sEM) to a final
value (3 hr) of 1.73 0.11 (P <0.0125 by repeated measures ANOVA);
in HS the drug had no effect (control:1.75 0.15; 3 hr:l.73 0.12).
The placebo did not cause any change in either group. The increase in
Valsalva maneuver ratio after Naloxone observed in UP was due to
lengthening of the RR interval during the release phase (longest
RR:control 850 120 msec, 3 hr 980 70 msec; P < 0.01) indicating
an enhanced parasympathetic activation. Strain phase RR interval
changes were unaffected by the drug. In conclusion, by enhancing the
parasympathetic activation of the release phase, Naloxone restores the
subnormal Valsalva maneuver ratio of chronic uremic patients. This
effect is likely due to antagonism of the depressant effect of
Metenkephalin on barorefiex sensitivity. Elevated plasma levels of
Metenkephalin may be responsible for the baroreflex dysfunction of
uremic patients.
3,3',S' Triiodothyronine (reverse T3) and glucose intolerance in
uremia: evidence of a useful indicator of carbohydrate metabolic control.
S. De Marchi, E. Cecchin, and F. Tesio. Department of Internal
Medicine, Hospital of Codroipo (Udine), Codroipo Unit of Nephrology
and Dialysis, Hospital of Pordenone, Pordenone, Italy. In endstage
renal disease glycosylated hemoglobins are not useful parameters of
long-term carbohydrate metabolic control. Recently low triiodothyro-
nine (T3) and raised 3,3',5' triiodothyronine (reverse T3 or rT3) levels
have been reported in uncontrolled diabetes mellitus. Thyroid status
has been extensively investigated in chronic renal failure. Previous
studies reported that serum T3 and thyroxine (T4) concentrations are
below the normal range in about one third of uremic patients. Little is
known about rT3 whose serum levels have been found to be either
normal or low or increased in uremia. The aims of this study are to
further elucidate these apparently controversial reports on rT3 in
chronic renal failure by attempting to assess the relation between
plasma glucose and thyroid hormone concentrations and to investigate
the possibility that rT3 may be an indicator of long-term carbohydrate
metabolic control in uremic patients on hemodialysis. We measured
pre-dialysis serum levels of T3, T4, rT3, TSH, insulin, glycemia, and
glycosylated hemoglobins (HbA1 and HbAlc) in 30 patients with
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endstage renal disease receiving long-term hemodialysis. An oral glu-
cose tolerance test (OGTT) was performed in all patients: 16 had a
normal glucose tolerance (NGT), and 14 had an impaired glucose
tolerance (IGT) according to the NDDG's criteria. Serum T4 and T3
levels were significantly reduced in uremic patients as compared with
those of a control group of 30 subjects well matched for age and sex.
TSH levels showed no difference between patients and controls.
Reverse T3 values varied considerably among patients being either
normal or low or slightly increased. There was no difference in the mean
values of T3 between patients with IGT and NGT. Contrarily rT3 was
significantly increased in patients with IGT as compared with those with
NGT (0.215 0.039 vs. 0.124 0.016 ng/ml; P < 0.0001). Reverse T3
showed positive relationships to pre-dialysis glycemia (P = 0.005) and
to the glycemic peak during the OGTT (P = 0.005); furthermore it
correlated to pre-dialysis insulinemia (P = 0.0017) and to the
insulinemic peak during the test (P < 0.0001). In contrast these
parameters of carbohydrate metabolic control did not correlate with T3
and glycosylated hemoglobins. No correlation was found between rT3
and dialytic age. In conclusion, these data might explain, at least in
part, the contrasting reports on rT3 levels in uremia suggesting that it
may be a useful indicator of carbohydrate metabolic control in patients
with endstage renal disease receiving long-term hemodialysis.
A new method for insertion of indwelling peritoneal dialysis catheter
(PC). N. Di Paolo, A. Manganelli, F. Strappaveccia, M. De Mia, and
E. Gaggiotti. Nephrology Department, Regional Hospital of Siena,
Siena, Italy. To eliminate the discomfort caused by surgical methods
and the risk involved using the Trocar, we have used a new technique
for insertion of the PC for 1 year. We devised a steel instrument,
vaguely resembling a rinoscope, composed of 2 semicones either 6 or
7.5 cm long with a rounded tip. The handles are connected by a screw
to permit dilatation of semicones. After a local anesthesia, an intro-
ducer needle is inserted into the peritoneal cavity. A guidewire is
passed through the needle which is then withdrawn and the instrument
is placed around the guide and gently pushed up to the peritoneal
cavity. The guide is then removed and squeezing the handles of the
instrument, we introduce the PC up to 2 cm beyond the first dacron cuff.
Once the PC is in place, the instrument is removed and a subcutaneous
tunnel may be made. There is a possibility that the needle may perforate
an intestinal loop, but when experimenting on dogs we observed that, in
this case, the instrument will press down the loop without piercing, and
when the guide is withdrawn, it remains in the abdominal cavity and the
PC will assume the correct position. We have used this method for 25
patients. Fourteen were new patients while 11 underwent the PC
repositioning. For all patients this new method proved to be excellent
with no leakage and PCs were utilized after only 24 hr. We emphasize
the brief time for PC insertion, the minimum discomfort, and simplicity
of the technique.
Pregnancy in women with chronic renal failure (CRF). E. Imbasciati,
P. Bozzetti, M. L. Airoldi, G. C. Ambroso, B. Pagliari, G. Pardi, E.
Massa, and P. Capetta. Divisione Nefrologia Ospedale Maggiore,
Clinica Ostetrica e Ginecologica I e II, Università di Milano, Milano,
Italy. The course of pregnancy (P) and its effect on renal disease in
women with CRF has been studied only in a few patients. The high rate
of fetal loss and worsening of renal function are reported. We describe
18 P in 18 patients with renal disease and serum creatinine  1.6 mg/dl
before P. Six patients had chronic glomerulonephritis; five, interstitial
nephritis; two, vascular disease; and five, undefined etiology. There
were two spontaneous abortions, two therapeutic abortions, one still-
birth, and 13 livebirths, six of them before the 36th week. Cesarean
section was done in 7 patients. Fetal weight was greater than 2500 g in
five newborns. Eight patients were hypertensive before P and two
became hypertensive during P. The effect of P on progression of renal
failure was evaluated in 13 patients in whom it was possible to calculate
the linear regression of reciprocal serum creatinine before and after P.
In eight patients the rate of progression did not change after P. One of
them had a marked increase of serum creatinine during P which
reversed after delivery. In three patients a decline of renal function
occurred during P and continued after delivery (two patients) or after
abortion (one patient). In two patients renal function remained stable
during P and progressively worsened after delivery. Arterial hyper-
tension was present before P in four of five patients who worsened and
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in three of eight who did not. In conclusion, Pin women with CRF may
end in a successful delivery, but it may be accompanied by a worsening
of renal function especially in hypertensive women.
The dopaminergic stimulation of transplanted kidney. G. Graziani, F.
Egidi, A. Morganti, C. Sala, F. Salerno, P. L. Incerti, E. Lorenzano, P.
Passerini, P. Ghirardi, and C. Ponticelli. Divisione di Nefrologia e
Dialisi Ospedale Maggiore, Clinica Medica III e IV Universita, Sez.
Ricerche Simes, Milano, Italy. The stimulation of renal vascular and
tubular dopaminergic receptors increases urinary flow, glomerular
filtration rate and the fractional excretion of sodium and potassium. To
investigate either the role of renal innervation or of the renal mass
reduction in response to an acute dopaminergic stimulation, 50 mg of
Ibopamine, an orally active dopamine derivative, were administered to
nine cadaveric transplant patients (TX), with normal and stable blood
creatinine levels, three subjects who had donated one kidney for
transplant (D) and the three related transplant recipients with a denerv-
ated kidney (R). The results were compared to those observed in six
healthy volunteers (C). Urinary flow (UV ml/min), glomerular filtration
rate (GFR mi/mm), fractional excretion of Na and K (FeNa% and
FeK%), and plasma renin activity (PRA ng/mllhr) were measured
before (time 0) and every 80 mm after Ibopamine administration. In the
table, ** indicate P < 0.001 and * P < 0,05 in respect to time 0.
Time
UV
TX C
GFR
TX C
0
80'
160'
240'
1.10
0.95
0.82
1.29
0.87
3.31*
1.85
2.33
94.7
101.6
70.0
82,5
104.6
206.l**
87.5
93.6
FeNa% FeK% PRA
Time TX C TX C TX C
0
80'
160'
240'
1.0
0.8
1.1
1.4
0.87
l.27**
l.36**
l.30**
11.7 6.3
13.2 13.5**
16.4 13.3*
20.4* 10.7*
2.5
2.6
2.6
3.0
0.5
0.3
0.2
0.2
The three D showed the same response of R and TX to dopaminergic
stimulation. In conclusion, uninephrectomized innervated or denerv-
ated patients showed submaximal glomerular hyperfiltration, since
GFR failed to increase in response to vascular receptors stimulation.
Ibopamine promoted Na and K excretion, by tubular receptors stimula-
tion, the latter becoming active also in denervated kidney. This
natriuretic and kaliuretic effect seems not to depend on GFR or PRA
modifications. The neural control of the kidney does not appear to play
a role in mediating the renal response to dopaminergic stimulation.
Erythroid colony formation in renal transplantation patients with
erythrocytosis. S. Lamperi and S. Carozzi. Division of Nephrology, St.
Martin Hospital, Genoa, Italy. In 55 renal transplantation patients,
erythrocytosis (E) was observed in six subjects with hematocrit (Hct)
and hemoglobin (Hb) mean values, respectively, 59 2% and 19 1
g/dl. All patients showed normal serum creatinine, blood pressure, and
respiratory function. In all patients, with or without E, the growth of
erythroid progenitor cells (BFU-e) drawn from peripheral blood was
evaluated in in vitro cultures. Moreover, in the same subjects, the
serum erythropoietin (S-Ep) levels by fetal mouse liver cell assay were
evaluated. The results showed a significant increase on the basal values
of S-Ep in E and in non-E patients, respectively, 400% and 492%, with
a subsequent decrease when Hct and Hb reached steady high levels,
showing that a feedback control system was restored in most of the
transplanted patients. Notwithstanding the diminution of S-Ep, on the
contrary, six patients demonstrated a further progressive rise of Hct
and Hb levels up to reach an erythrocytosic state. In in vitro cultures
the peripheral BFU-e of these patients, showed a noticeable sensitivity
to the progressively reduced doses of Ep and also to be capable of
developing a few colonies per plate when the medium was Ep free,
while in non-E patients, the BFU-e growth needed the addition of the
high dose of Ep. These results were not verified using peripheral blood
depleted of monocyte and/or T-lymphocyte cells. Therefore, in trans-
planted patients with E it is possible that particular cellular interactions
and/or the product of their secretion stimulate an early hyperprolifera-
tion of BFU-e with a greater Ep sensitivity but at least partly with the
capacity of growing also in the absence of Ep.
Cytoplasmic free (Ca2) in blood cells in hypertension (HT). G.
Bruschi, A. Cavatorta, M. E. Bruschi, C. Pavarani, G. Orlandini, M.
Spaggiari, M. Caroppo, L. Tacinelli, and A. Borghetti. Medical Clinic
and Nephrology, University of Parma, Parma, Italy. There have been
reports suggesting an altered control of cellular calcium in HT. How-
ever, the cytosolic-free calcium concentration (the pool playing the vital
role in regulating many cell activities) has never been measured reliably
and nondisruptively in small blood cells. We used the membrane-
permeant fluorescent Ca indicator Quin 2. Data on platelets and
lymphocytes of essential hypertensive patients (EHP), normotensive
control subjects (NCS), spontaneously hypertensive rats (SHR), and
Wistar-Kyoto rats (WKY) at different ages are illustrated in the table
below. All results are expressed in nmoles/liter as mean SEM.
Lymphocytes P Platelets P
EHP
NCS
120.5 4.8
112.2 4.8 NS
144.9 6.4
126.6 5.1 0.05
Lympho-
cytes 4 weeks P 8 weeks P 14 weeks P
SHR
WKY
122.2 5.7
124.5 6.2 NS
118.1 3.2
108.2 5.1
NS 121.3 5.0
99.4 6.7 0.05
Platelets 4 weeks P 8 weeks P 20 weeks P
SHR
WKY
129.9 8.2
124.2 8.4 NS
146.4 8.6
103.1 6.2
0001 170.6 11.1
83.0 0.001
The following conclusions can be drawn: (1) (Ca2)1 is higher in
hypertension than in normotension; (2) differences are more evident in
platelets than in lymphocytes; (3) differences are greater in hyper-
tensive rats than in humans in comparison with the respective
normotensive counterpart; (4) abnormality of (Ca2) evolves roughly
pan passu with the development of high blood pressure. Attempts were
done to elucidate the mechanism of the increased (Ca2 f)1 in blood cells
in HT. In lymphocytes, increasing (Ca2)0 led to a comparable, though
slight, increase in (Ca2)1 in SHR and WKY; (SHR from 146 to 220 nm,
WKY from 85 to 148 nm). Lowering (Ca2)0 to 100 n again led to a
comparable slight decrease of (Ca2)1 in SHR and WKY. Since the
force driving the influx of Ca2 into the cells and activating the outward
Ca2 pump should be abolished at 100 nM (Ca2)0, the higher (Ca2)1 in
SHR under these conditions must be at least partly contributed by
exchange with intracellular stores. Addition of cathecolamines in vitro
produced no effects in (Ca2)1 in lymphocytes, thus discounting a role
of this agent in abnormal cellular (Ca2) regulation. Addition of
ouabain, increasing (Na)1, had no effect on (Ca2)1 suggesting that at
least in lymphocytes (Nat) does not participate in (Ca2)1 regulation
and to its alterations in HT. These results suggest a generalized defect
of cytoplasmic (Ca2) control in HT. Investigations are now extended
to tissues (synaptosomes and arterial myocytes) more directly involved
in blood pressure regulation.
Increased urinary calcium excretion of hypertensive patients is due to a
reduced tubular calcium reabsorption. M. Cirillo, P. Strazzullo, A.
Siani, F. Galletti, and V. Nunziata. Department of Internal Medicine,
II Medical School, University of Naples, Naples, Italy. Urinary cal-
cium (Ca) excretion rate has been investigated in untreated essential
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hypertensive patients with normal renal function and no target organ
disease. Hypertensives (N = 60) showed significantly higher 24-hr
urinary Ca excretion (+ 27%, P < 0.01), as well as increased levels of
plasma parathyroid hormone (+28%, P < 0.05) and urinary cyclic
adenosinemonophosphate (+ 33%, P < 0.001) compared to healthy
normotensive controls (N = 60), while no difference was observed
regarding serum Ca levels between the two groups. Urinary Ca excre-
tion under fasting conditions was also higher (+ 40%, P < 0.001) in
hypertensives (N = 30) than in normotensives (N = 30). In the course
of a constant rate intravenous Ca load (15 mg Ca/kg body wt/3 hr)
hypertensive patients (N = 14) had a higher urinary Ca excretion rate
than control subjects (N = 12) at all levels of serum Ca and indepen-
dently from the difference in glomerular filtration rate. The regression
line of urinary Ca excretion rate on serum Ca level had in the
hypertensive subjects a significantly increased slope (+ 35%, P < 0.01)
compared to that of control subjects: This finding could indicate an
abnormality in tubular Ca reabsorption in the proximal tubule. The
theoretical threshold for renal Ca excretion (indicated by the x axis
intercept of this regression line) was reduced, but not significantly, in
hypertensive patients (— 3%). As it was reported that parathyroid
overactivity increases the value of the renal Ca threshold, we can
hypothesize that the parathyroid activity, which is enhanced in hyper-
tensive patients, compensates to some degree for a proximal Ca leak by
increasing Ca reabsorption in the distal nephron. The basal phosphate
clearance, somewhat higher in hypertensive patients (+ 15%, P < 0.05),
makes rather unlikely the hypothesis that the tubular abnormality of
these patients was located in the distal nephron. In conclusion, hyper-
tensive patients had a higher urinary Ca excretion rate despite normal
serum Ca levels and mild parathyroid overactivity: This abnormality
seems to be due to an altered tubular Ca reabsorption probably located
in the proximal tubule.
Blood pressure and exchangeable sodium during sodium depletion in
normal subjects and in essential hypertensive subjects. C. Zoccali, D.
Davis, R. Fraser, J. J. Brown, A. F. Lever, and J. I. S. Robertson.
Centro Fisiologia C/mica CNR, Reggio Calabria, Italy, and MRC
Blood Pressure Unit, Glasgow, Great Britain. In patients with essential
hypertension arterial pressure is directly related to exchangeable so-
dium, but no such relationship has been found in normal subjects. A
possible explanation of this phenomenon is that body sodium may
change in normal subjects without a change of blood pressure but that
in essential hypertensive subjects the same change of body sodium
alters arterial pressure. We have measured blood pressure, exchange-
able sodium, sodium balance, and plasma concentration of active renin
and aldosterone in seven normal men and in ten essential hypertensive
subjects of similar age and weight. Each subject was studied in two
occasions: during a 3-day period of fixed, normal sodium intake (150
mmoles/day) and during a period of sodium depletion produced by a
single dose of furosemide (40 mg) followed by 3 days of low sodium
intake (10 mmoles/day). The order of the two periods was randomized.
Sodium depletion caused a similar reduction of exchangeable sodium in
the two groups (essential hypertensives: —7.1 3.8%; normal sub-
jects: —7.0 3.3%) but, on the average, mean blood pressure changed
more in essential hypertensives (—15 12 mm Hg) than in normal
subjects (+ 3.8 6mm Hg) (P < 0.01). The five patients showing the
greatest arterial pressure fall had a lower rise of plasma renin (+ 179%)
and aldosterone (+ 59%) in comparison with the five patients having the
least arterial pressure change (renin + 752%, aldosterone + 178%). The
findings are compatible with a model of pressure-natriuresis which
alters more in normal subjects during changes of dietary sodium thereby
preventing a rise of arterial pressure. Failure of this compensatory
mechanism may raise blood pressure.
The acute antihypertensive effect of captopril and nifedipine is en-
hanced in the upright position by different sympathoinhibitory mecha-
nisms. A. Morganti, C. Sala, L. Turolo, A. Palermo, and A. Zanchetti.
Institutes of Clinica Medica IV and IX, University of Milan and Centro
di Fisiologia Clinica e Ipertensione, Ospedale Maggiore, Milan, Italy.
Both converting enzyme inhibitors and calcium antagonists have the
potential of interfering with sympathetic nervous system activity; if this
sympathoplegic action is relevant one might expect that their
antihypertensive effect is potentiated by orthostasis. To define whether
and how this indeed occurs, we measured systolic and diastolic blood
pressures (SBP and DBP mm Hg), heart rate (HR b/mm), plasma
noradrenaline (NA pg/mI) and plasma renin activity (PRA ng/ml/hr) in
the supine (S) position and after 30 mm of upright (U) position, in 14
patients with essential hypertension before and after the oral adminis-
tration of either 25 mg captopril (C) or 10 ng nifedipine (N). In control
studies U and S SBP were similar whereas DBP, HR, NA, and PRA
were always increased by U (P < 0.01 at least). The administration of
C had no effect in S except that PRA was increased (from 0.8 0.2 to
1.2 0.4); in contrast, after U, SBP was always lower than in control
studies (148 6 vs. 167 6, P < 0.01) and DBP was unchanged with
respect to the values in S (103 5 vs. 102 3). Despite this depressor
effect, after U both HR and NA values were similar to those before C
(respectively, 84 5 vs. 87 4 and 453 22 vs. 473 40) whereas
PRA was much higher (2.9 0.8 vs. 1.3 0.3). The administration of
N lowered both SBP and DBP in S (from 165 8 to 151 6 and from
100 5 to 92 4, P < 0.05) and this effect was associated with
significant increments (P < 0.05 at least) of HR (from 72 3 to 83
3), NA (from 291 19 to 370 20) and PRA (from 0.8 0.2 to 1.0
0.2). After U, SBP decreased further to 135 5 whereas DBP remained
as in S (95 4); in addition HR, NA, and PRA increased more than in
control conditions (respectively, to 101 4, 620 33 and 1.9 0.3).
In nine patients restudied again, according to the same protocol, after 5
days of diuretic therapy both C and N induced, again, an equal and
additional depressor effect in U; however, while after C the U values of
HR and NA were similar to those seen in control conditions (respec-
tively, 89 7 and 88 4 and 645 23 and 617 27), after N both
these parameters were clearly much higher (108 5 and 731 29, P <
0.01). The observation that the acute administration of C and N has a
greater hypotensive effect in U than in S indicates that both these drugs
interfere with the response of the sympathetic nervous system to the
postural stimulus; however, while the sympathoplegic effect of C is
apparently due to a blunted reflex activation, either centrally or
peripherally, that of N seems dependent on a diminished vascular
responsiveness to the adrenergic stimulus.
H2 parathyroid receptors and 1-25(OH)2 therapy in uremia on regular
dialysis treatment (RDT). F. Antonucci, P. Messa, D. Montanaro, M.
Adorati, M. Messa, G. Paviotti, A. Favazza, G. Mioni, M. Cecchettin,
and E. Bonucci. Servizio Nefrologia O.C. Udine, III Servizio Anal isi
O.C. Brescia, Istituto Anatomia Patologica Universitd Roma, Rome,
Italy. Our previous study evaluated the parathyroid gland response
(PTH-NH2 1-34) to an intravenous cimetidine load (200 mg) in 30 uremic
patients on RDT with a variable degree of secondary hyperpara-
thyroidism (HPT) proven by bone biopsy. Out of this population we
selected three groups of five patients characterized by a decrease (group
A), increase (group B), and unchanged (group C) PTH-NH2 secretion.
We treated all these patients with 1-25(OH)2 for 12 months (0.25 to I
pg/day). Serum Ca, sP, PTH-COOH(65-84), PTH-NH2(l-84), and AP
were measured before starting the treatment and every 3 months.
Radiographic film of hands were obtained before and after the therapy.
The patients as a whole showed an increase of sCa (P < 0.05), sP (P <
0.01), and a decrease of PTH-COOH (P < 0.01), PTH-NH2 (P < 0.01),
AP (P < 0.01). An inverse correlation between basal and maximal
percent variations of sCa were found (P < 0.01). Furthermore, basal
sCa levels inversely correlated with maximal percent variations of
PTH-NH2 (P < 0.01) and the variations of sCa resulted inversely
correlated with percent variations of PTH-NH2 (P < 0.01). When we
considered the response to 1-25 treatment in the three groups, we found
an early and significant fall of PTH-NH2 (P < 0.01) in group A, no
variations in group B and a late (ninth month) significant fall (P < 0.05)
in group C. Alkaline phosphatase reduced in all groups (P < 0.01).
Radiographic hand film showed a marked reduction of osteolysis in
group A; on the contrary, in three patients of group B there was a clear
worsening and no significant variations were observed in group C. The
percent fall of PTH-NH2 1-34 induced by cimetidine test in group A
significantly correlated with the final percent fall of PTH-NH2 1-84
produced by 1-25 in the same group (P < 0.05). We conclude that the
sCa levels and the type of response to cimetidine test may be predictive
of the effect of 1-25 on secondary HPT in patients on RDT.
Nitrogen balance and growth in children on hemofiltration. M. Giani,
M. Picca, I. Ghio, A. Saccaggi, R. Galato, L. Romeo, V. Cecchetti,
and A. Edefonti. Pediatric Dialysis Unit, University of Milan, Milan,
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Italy, Malnutrition and wasting are commonly seen in uremic pediatric
patients treated with hemodialysis (HD) and aee reported to have an
adverse effect on growth rate (GR). Such data are still lacking for
hernofiltration (HF). Comparative influence of HD and HF on nitrogen
balance (Nb) and GR was investigated in eight children (11.45 2.8
years), treated first with HD for 25.7 11.9 months and afterwards
with HF for 21.6 4.2 months. HF was prescribed on the basis of urea
generation rate (Gu). Nb was evaluated every 2 months by the differ-
ence between dietary protein intake (DPI) and protein catabolic rate
(PCR). There was no significant difference for energy and protein intake
in HD compared with HF. Results were determined as mean (SD).
Gu
mg/mm
PCR
glkg/day
Nb
mg/kg/day
GR
cm/year
MD 3.8(0.9) 2.04(0.6) 6.14(124) 1.9(1.1)
HF 2.7(0.43) 1.29 (0.5) 186 (97) 3.9(0.4)
P 0.01 0.02 0.01 0.001
in conclusion, during the HF period, our patients improved their Nb
and GR. Even if many other factors contribute to impaired growth, a
positive Nb seems to play a key role to maximize growth potential.
Ultrasonically guided fine-needle alcoholization (UGFNA) as support to
medical treatment of secondary hyperparathyroidism (sHPT). A.
Giangrande, P. Cantu', L. Solbiati, and C. Ravetto. General Provincial
Hospital, Busto Arsizio, italy. sHPT frequently complicates the clinical
course of chronic uremia, although more active vitamin D metabolites
are now available. Parathyroid hyperplasia which sustains this pattern
is seldom influenced by medical treatment and may require
parathyroidectomy (PTX). As an alternative to surgery, in selected
cases (single hyperplasia, uneffective subtotal PTX, seriously ill pa-
tient, refusal to surgery), we obtained a reduction of parathyroid mass
by UGFNA. Ten out of 88 patients (3 M, 7 F, aged 34 to 69, on
hemodialysis from 65 to 176 months) with symptomatic sHPT and
positive US scan were treated with one infiltration of 0.6 to 1.2 ml
sterile absolute ethanol introduced with a disposable needle (22G, 95
mm long). The US diagnosis was preliminarily confirmed with fine-
needle aspiration biopsy and/or iPTH assay of aspirated material. The
technique, always well tolerated, produced an evident change f
echopattern already present after 1 to 2 weeks. In eight patients a
remarkable reduction (up to 100%) of gland size was noted after 6
months from alcoholization, while the lesions were replaced by either
fibrotic pattern or small liquid areas. With a single lesion, a reduced
incidence of vitamin D hypercalcemia and a permanent improvement of
bone alkaline phosphatase and iPTH was documented.
Intestinal absorption In nephrotic syndrome. C. Pecoraro, M. Usberti,
B. Guida, A. Romano, L. Grumetto, L. Carbonaro, A. Pinto, andM. T.
Saravo. Pediatric Clinic and Department of Medical Nephrology, ii
Faculty of Medicine and Surgery, University of Naples, Napoli, Italy.
Intestinal absorption, as it has been recently shown in experimental
animals, is decreased in nephrotic syndrome (NS). In this study we
evaluated intestinal transport in a children's group with NS by tech-
niques commonly used for this purpose in pediatric gastroenterology.
Ten children (5 boys and 5 girls, mean age, 5.2 years) with NS and
normal GFR were studied; none took steroid treatment and every
therapy was stopped from at least 10 days at the study's time. Intestinal
absorption was estimated by these tests: (1) D-xylose absorption test,
(2) oral iron loading test, (3) oral triglycerides loading test. The results
were compared to those of 12 children (7 boys and 5 girls; mean age, 4.5
years) without renal or intestinal pathology. Nephrotic children had
significantly lower basal plasma albumin, serum iron, and transferrin
levels, but higher plasma triglyceride levels than the control group.
Serum xylose, iron, and triglyceride concentrations after respective
loads were significantly lower in nephrotic children than in the control
group, without a correlation between basal levels of these substances
and their increase after the load. A statistically significant correlation
was established between plasma albumin concentration and a rise in
xylose (P < 0.01), serum iron (P < 0.01) and plasma triglycerides (P <
0.05) levels. Because intestinal epithelium is structural and functional
similar to that of the proximal tubule, these results agree with the
studies which have shown in NS tubular proximal absorption decrease
for hypoalbuminemia and, therefore, for decreased plasma oncotic
pressure in peritubular capillaries. Our study shows that intestinal
absorption in NS is generally and not specifically decreased; the plasma
albumin level may play an important role in decreasing intestinal
transport, although the possibility exists that other factors are also
involved.
